Clinical Pharmacology Study of FYU-981 for Subjects With Hepatic Insufficiency
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2018
At a glance
- Drugs Dotinurad (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Mochida Pharmaceutical
- 21 Sep 2018 Status changed from recruiting to completed.
- 16 Nov 2017 Status changed from not yet recruiting to recruiting.
- 13 Oct 2017 New trial record